BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37731472)

  • 1. Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers.
    Azin M; Ngo KH; Hojanazarova J; Demehri S
    JID Innov; 2023 Nov; 3(6):100221. PubMed ID: 37731472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
    Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S
    J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
    Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Treatment of Topical Imiquimod Plus Anti-PD-1 Antibody Exerts Significantly Potent Antitumor Effect.
    Oya K; Nakamura Y; Zhenjie Z; Tanaka R; Okiyama N; Ichimura Y; Ishitsuka Y; Saito A; Kubota N; Watanabe R; Tahara H; Fujimoto M; Fujisawa Y
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
    Sun J; Dou W; Zhao Y; Hu J
    Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):17-24. PubMed ID: 24286371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells.
    Yokogawa M; Takaishi M; Nakajima K; Kamijima R; Digiovanni J; Sano S
    Mol Carcinog; 2013 Oct; 52(10):760-9. PubMed ID: 22431065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
    Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
    Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment.
    Shen N; Wu J; Yang C; Yu H; Yang S; Li T; Chen J; Tang Z; Chen X
    Nano Lett; 2019 Nov; 19(11):8021-8031. PubMed ID: 31558024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
    Mohney L; Singh R; Grada A; Feldman S
    J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
    Rosenberg AR; Tabacchi M; Ngo KH; Wallendorf M; Rosman IS; Cornelius LA; Demehri S
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30895944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcipotriol, a synthetic Vitamin D analog, promotes antitumor immunity via CD4+T-dependent CTL/NK cell activation.
    Kim H; Kim J; Sa JK; Ryu BK; Park KJ; Kim J; Ha H; Park Y; Shin MH; Kim J; Lee H; Kim D; Lee K; Jang B; Lee KM; Kang SH
    Biomed Pharmacother; 2022 Oct; 154():113553. PubMed ID: 35994815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
    Huang SW; Wang ST; Chang SH; Chuang KC; Wang HY; Kao JK; Liang SM; Wu CY; Kao SH; Chen YJ; Shieh JJ
    J Invest Dermatol; 2020 Sep; 140(9):1771-1783.e6. PubMed ID: 32035924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery.
    Panoutsopoulou E; Zbytovská J; Vávrová K; Paraskevopoulos G
    Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma.
    Cho JH; Lee HJ; Ko HJ; Yoon BI; Choe J; Kim KC; Hahn TW; Han JA; Choi SS; Jung YM; Lee KH; Lee YS; Jung YJ
    Oncotarget; 2017 Apr; 8(15):24932-24948. PubMed ID: 28212561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
    Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
    J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment of melanoma skin metastases with imiquimod: a review.
    Sisti A; Sisti G; Oranges CM
    Dermatol Online J; 2015 Feb; 21(2):. PubMed ID: 25756475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.
    Mauldin IS; Wages NA; Stowman AM; Wang E; Olson WC; Deacon DH; Smith KT; Galeassi N; Teague JE; Smolkin ME; Chianese-Bullock KA; Clark RA; Petroni GR; Marincola FM; Mullins DW; Slingluff CL
    Cancer Immunol Immunother; 2016 Oct; 65(10):1201-12. PubMed ID: 27522582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.